ArticleJournal of translational medicine2026

The HKDC1-ASS1-ACSBG2 axis reprograms lipid metabolism to drive therapeutic resistance in hepatocellular carcinoma.

Xiangyu Ling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.